بدائل البحث:
significant decrease » significant increase (توسيع البحث), significantly increased (توسيع البحث)
effects decrease » effects decreased (توسيع البحث), effects regress (توسيع البحث)
significant decrease » significant increase (توسيع البحث), significantly increased (توسيع البحث)
effects decrease » effects decreased (توسيع البحث), effects regress (توسيع البحث)
-
301
Shares of antibiotic substances on total prescription by quarter from 2013 to 2019 for female and male patients with UTI (N39.0, N30.0)(female: n = 1.681.255 prescriptions; male: n...
منشور في 2024الموضوعات: "…fluoroquinolone shares decreased…"
-
302
Shares of specialist groups prescribing 1<sup>st</sup>, 2<sup>nd</sup>, and 3<sup>rd</sup> antibiotic prescriptions in UTI treatment of females (N39.0, N30.0) in 2018 and 2019.
منشور في 2024الموضوعات: "…fluoroquinolone shares decreased…"
-
303
Number of antibiotic prescriptions in female and male patients with UTI (N30.0 and/or N39.0).
منشور في 2024الموضوعات: "…fluoroquinolone shares decreased…"
-
304
Shares of antibiotic substances on total prescription in female patients with UTI (N39.0, N30.0) by physician specialties (GPs: n = 1.299.641 prescriptions; gynecologists n = 141.8...
منشور في 2024الموضوعات: "…fluoroquinolone shares decreased…"
-
305
Comparison of 1<sup>st</sup>, 2<sup>nd</sup>, and 3<sup>rd</sup> antibiotic prescription.
منشور في 2024الموضوعات: "…fluoroquinolone shares decreased…"
-
306
UTI diagnoses by sex and physician specialty (2013–2019).
منشور في 2024الموضوعات: "…fluoroquinolone shares decreased…"
-
307
-
308
Tests of Direct Effects of Burnout and Resilience on Stress Specific to COVID-19 and PTS at T3.
منشور في 2025الموضوعات: -
309
-
310
-
311
Summary of post-treatment disease course measures from MDMA-AT publications.
منشور في 2025الموضوعات: -
312
-
313
Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.
منشور في 2025الموضوعات: -
314
-
315
-
316
-
317
Summary of post-treatment disease course measures from off-label medications clinical trials.
منشور في 2025الموضوعات: -
318
Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.
منشور في 2025الموضوعات: -
319
Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes.
منشور في 2025الموضوعات: -
320
Summary of post-treatment disease course measures from clinical trials with psychotherapies.
منشور في 2025الموضوعات: